Anti-CD3E Recombinant Antibody (Visilizumab)

CAT#: TAB-714

Recombinant humanized (from mouse) antibody expressed in CHO binding to human CD3 receptor. Visilizumab is a humanized monoclonal antibody. It is being investigated for use as an immunosuppressive drug in patients with ulcerative colitis and Crohn's disease.

Gene Expression
Figure 1 IF staining of human cell line JURKAT Figure 2 Lymph node Figure 3 RNA cell line category: Group enriched (JURKAT, MOLT-4)

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Mouse
  • Derivation
  • Humanized (from mouse)
  • Type
  • IgG2
  • Species Reactivity
  • Human
  • Applications
  • Suitable for use in FuncS, IF, Neut, ELISA, FC, IP, ICC and most other immunological methods.
  • Trade name
  • nuvion
  • CAS
  • 219716-33-3
  • Generic Name
  • visilizumab
  • Related Disease
  • Kidney transplantation

Product Property

  • Purity
  • >95.0% as determined by Analysis by RP-HPLC & analysis by SDS-PAGE.
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • visilizumab;nuvion;219716-33-3;HuM291;SMART Anti-CD3;CD3E;CD3e molecule, epsilon (CD3-TCR complex);CD3e antigen, epsilon polypeptide (TiT3 complex);T-cell surface glycoprotein CD3 epsilon chain;CD3-epsilon;T-cell surface antigen T3/Leu-4 epsilon chain;T-c
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for TAB-714. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biosimilar Overview

Please refer to Visilizumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Visilizumab.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "Visilizumab"

Anti-Human CD3E Recombinant Antibody (Visilizumab)
Recombinant monoclonal antibody to CD3E. Visilizumab is a humanized monoclonal antibody that can be potentially used in the treatment of Allograft rejection, Psoriasis, Autoimmune diseases.
Afuco™ Anti-CD3E ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-714)
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized (from mouse) antibody expressed in CHO binding to human CD3 receptor. It is a humanized monoclonal antibody. It is being investigated for use as an immunosuppressive drug in patients with ulcerative colitis and Crohn's disease.
DrugMonitor™ Anti-Visilizumab Antibody (VS-1224-YC1307)
Visilizumab has been investigated for ulcerative colitis treatment. The DrugMonitor™ Anti-Visilizumab Antibody (VS-1224-YC1307) is an anti-drug antibody (ADA) against Visilizumab. This drug-based antibody is raised in mice immunized with the Visilizumab. The anti-Visilizumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Visilizumab in samples.

See other products for "CD3E"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
TAB-H28 Anti-Human CD3E Recombinant Antibody (Ertumaxomab) ELISA, FC, IP, FuncS, IF, Neut, ICC IgG2a / G2b
CAT Product Name Application Type
TAB-159 Anti-Human CD3E Recombinant Antibody (TAB-159) Neut, ELISA, IF, IP, FuncS, FC, ICC IgG1 - kappa
TAB-H52 Anti-Human CD3E Recombinant Antibody (TAB-H52) FC, IP, ELISA, Neut, FuncS, IF, WB IgG1 - lambda
TAB-420CQ Anti-Human CD3E Recombinant Antibody (Visilizumab) ELISA, IHC, FC, IP, IF, FuncS IgG2, κ
CAT Product Name Application Type
TAB-245 Anti-Human CD3 epsilon Recombinant Antibody (TAB-245) WB, ELISA, FC, IP, FuncS, IF, Neut IgG1 - kappa
TAB-124CL Human Anti-CD3E Recombinant Antibody (TAB-124CL) ELISA Human IgG
CAT Product Name Application Type
AGTO-G010E Anti-CD3E immunotoxin UCHT1 (scFv)-PE Cytotoxicity assay, Function study
AGTO-G010D Anti-CD3E immunotoxin UCHT1 (scFv)-DT Cytotoxicity assay, Function study
AGTO-G010R Anti-CD3E immunotoxin UCHT1 (scFv)-RTA Cytotoxicity assay, Function study
AGTO-L049E Anti-CD3E immunotoxin (IgG)-PE Cytotoxicity assay, Functional assay
AGTO-L049D Anti-CD3E immunotoxin (IgG)-DT Cytotoxicity assay, Functional assay
CAT Product Name Application Type
AFC-TAB-159 Afuco™ Anti-CD3E ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-159) Neut, ELISA, IF, IP, FuncS, FC ADCC enhanced antibody
AFC-TAB-245 Afuco™ Anti-CD3E ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-245) ELISA, FC, IP, FuncS, IF ADCC enhanced antibody
AFC-TAB-H52 Afuco™ Anti-CD3E ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-H52) FC, IP, ELISA, Neut, FuncS, IF ADCC enhanced antibody
AFC-TAB-714 Afuco™ Anti-CD3E ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-714) FuncS, IF, Neut, ELISA, FC, IP ADCC enhanced antibody
AFC-TAB-019 Afuco™ Anti-CD3E ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-019) FC, IP, ELISA, Neut, FuncS, IF ADCC enhanced antibody
CAT Product Name Application Type
VS-0724-XY17 Mouse Anti-CD3E Agonistic Antibody (VS-0724-XY17) FC, IP, ICC, Agonistic assays Mouse IgG1
CAT Product Name Application Type
VS-0724-YC1433 AbPlus™ Anti-CD3E Magnetic Beads (VS-0724-YC1433) IP, Protein Purification
CAT Product Name Application Type
VS-1024-XY94 Mouse Anti-NHP CD3E Recombinant Antibody (clone FN-18) ELISA Mouse IgG1
CAT Product Name Application Type
VS-0325-FY110 Human Anti-CD3E (clone NI-0401) scFv-Fc Chimera ELISA Human IgG1, scFv-Fc
CAT Product Name Application Type
VS-0425-YC355 Recombinant Anti-CD3E Vesicular Antibody, EV Displayed (VS-0425-YC355) ELISA, FC, Neut, Cell-uptake
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare